Lai nodro\u0161in\u0101tu uz\u0146\u0113muma att\u012bst\u012bbas pl\u0101nos paredz\u0113to medikamentu ra\u017eo\u0161anu, Baltij\u0101 viens no vado\u0161ajiem z\u0101\u013cu ra\u017eot\u0101jiem AS \u201cOlpha\u201d ieg\u0101d\u0101jies un uzst\u0101d\u012bjis jaunas ra\u017eo\u0161anas iek\u0101rtas par kop\u0113jo summu 4,4 miljoni eiro.<\/p>\n
Kopum\u0101 projekt\u0101 uzst\u0101d\u012btas \u010detras jaunas iek\u0101rtas, kas pal\u012bdz\u0113s b\u016btiski k\u0101pin\u0101t ra\u017eo\u0161anas jaudas, \u0146emot v\u0113r\u0101, ka tuv\u0101kajos gados uz\u0146\u0113mums pl\u0101no Eiropas, Lielbrit\u0101nijas un citos pasaules tirgos pied\u0101v\u0101t v\u0113l vismaz 50 jaunus patentbr\u012bvos medikamentus.<\/p>\n
\u0160\u0101 gada ruden\u012b darbu s\u0101ka jaun\u0101 blister\u0113\u0161anas un iepako\u0161anas l\u012bnija, kuras izveid\u0113 ieguld\u012bti vair\u0101k nek\u0101 2,5 miljoni eiro. T\u0101pat par 356 750 eiro uzst\u0101d\u012bts kompaktors jeb iek\u0101rta, ko izmanto saus\u0101s granulu z\u0101\u013cu formas izveidei. 800 000 eiro ieguld\u012bti jauna table\u0161u apvalko\u0161anas katla ieg\u0101dei, k\u0101 ar\u012b par v\u0113l 700 000 eiro uzst\u0101d\u012bta jauna z\u0101\u013cu kapsul\u0113\u0161anas iek\u0101rta. Kop\u0113j\u0101m invest\u012bcij\u0101m pie\u0161\u0137irts valsts atbalsts 30% apm\u0113r\u0101 no iek\u0101rtu ieg\u0101des izmaks\u0101m atbalsta programmas \u201cLielo invest\u012bciju aizdevums ar kapit\u0101la atlaidi\u201d ietvaros, sadarbojoties ar Latvijas Invest\u012bciju un att\u012bst\u012bbas a\u0123ent\u016bru un AS \u201cAtt\u012bst\u012bbas finan\u0161u instit\u016bciju ALTUM\u201d.<\/p>\n
\u201cK\u0101 vienu no sav\u0101m priorit\u0101t\u0113m esam izvirz\u012bju\u0161i ar\u012b za\u013c\u0101ku, efekt\u012bv\u0101ku un ilgtsp\u0113j\u012bg\u0101ku ra\u017eo\u0161anas procesu. Turkl\u0101t, arvien saasinoties situ\u0101cijai darba tirg\u016b, neizb\u0113gama ra\u017eo\u0161anas un pako\u0161anas darbu automatiz\u0101cija, kas \u013cauj mums nodro\u0161in\u0101t nepiecie\u0161amos ra\u017eo\u0161anas apjomus un efektivit\u0101ti vis\u0101 proces\u0101. T\u0101 k\u0101 m\u016bsu amb\u012bcijas ir Latvij\u0101 turpin\u0101t att\u012bst\u012bt un stiprin\u0101t z\u0101\u013cu ra\u017eo\u0161anu un farm\u0101cijas nozari kopum\u0101, kas ir ar augstu pievienoto v\u0113rt\u012bbu valsts ekonomikai un eksporta potenci\u0101lu , tad attiec\u012bgi ar\u012b veicam invest\u012bcijas, lai \u0161os m\u0113r\u0137us sasniegtu,\u201d uzsver AS \u201cOlpha\u201d valdes priek\u0161s\u0113d\u0113t\u0101js Juris Bundulis.<\/p>\n
Jaunais apvalko\u0161anas katls un jaun\u0101 kapsul\u0113\u0161anas ma\u0161\u012bna sniedz iesp\u0113ju divas reizes palielin\u0101t ra\u017eo\u0161anas jaudas. Ja agr\u0101k vienas stundas laik\u0101 var\u0113ja sara\u017eot 42 t\u016bksto\u0161us kapsulu, tad ar jauno kapsul\u0113\u0161anas ma\u0161\u012bnu \u2013 84 t\u016bksto\u0161us.<\/p>\n
\u201cM\u016bsu strat\u0113\u0123ija balst\u0101s uz trim pamatv\u0113rt\u012bb\u0101m \u2013 ilgtsp\u0113ju, inov\u0101cij\u0101m un eksportsp\u0113jas stiprin\u0101\u0161anu. Invest\u0113jot modern\u0101s ra\u017eo\u0161anas iek\u0101rt\u0101s, za\u013caj\u0101 ener\u0123ij\u0101 un digitaliz\u0101cij\u0101, stiprin\u0101m \u201cOlpha\u201d konkur\u0113tsp\u0113ju un veidojam ar\u012b b\u016btisku pienesumu Latvijas ekonomikai. Vienlaikus, k\u0101 viet\u0113jais z\u0101\u013cu ra\u017eot\u0101js, redzam iesp\u0113ju ar pla\u0161\u0101ku z\u0101\u013cu portfeli samazin\u0101t ar\u012b Latvijas importa atkar\u012bbu. 95% no z\u0101l\u0113m Latvij\u0101 tiek import\u0113tas, kas pieg\u0101\u017eu p\u0101rr\u0101vumu gad\u012bjumos rada augstus riskus ikvienam Latvijas pacientam. T\u0101p\u0113c ir m\u0113r\u0137tiec\u012bgi j\u0101att\u012bsta Latvijas farm\u0101cijas un z\u0101\u013cu ra\u017eo\u0161anas nozare, kas tik att\u012bst\u012bt\u0101 l\u012bmen\u012b nav ne Lietuv\u0101, ne Igaunij\u0101, \u201d uzsver J.Bundulis.<\/p>\n
Saska\u0146\u0101 ar uz\u0146\u0113muma ilgtermi\u0146a att\u012bst\u012bbas strat\u0113\u0123iju, AS \u201cOlpha\u201d produktu portfe\u013ca att\u012bst\u012bb\u0101, ra\u017eo\u0161anas iek\u0101rtu moderniz\u0101cij\u0101 un jaudu palielin\u0101\u0161an\u0101 jaunu produktu ievie\u0161anai, k\u0101 ar\u012b \u201cza\u013co\u201d tehnolo\u0123isko procesu att\u012bst\u012bb\u0101 kopum\u0101 piecu gadu period\u0101 pl\u0101no invest\u0113t 100 miljonus eiro. Apjom\u012bg\u0101k\u0101s invest\u012bcijas tiek veiktas jaunu patentbr\u012bvo z\u0101\u013cu izstr\u0101dei un produktu portfe\u013ca papla\u0161in\u0101\u0161anai.<\/p>\n
AS \u201cOlpha\u201d (agr\u0101k \u201cOlainfarm\u201d) ir viens no liel\u0101kajiem uz\u0146\u0113mumiem Baltijas valst\u012bs ar 50 gadu pieredzi z\u0101\u013cu un citu farmaceitisko produktu ra\u017eo\u0161an\u0101. Uz\u0146\u0113muma produktu kl\u0101sts nep\u0101rtraukti att\u012bst\u0101s un papla\u0161in\u0101s, \u0161obr\u012bd taj\u0101 ietilpst vair\u0101k nek\u0101 70 gatav\u0101s z\u0101\u013cu formas, vair\u0101k nek\u0101 20 akt\u012bv\u0101s farmaceitisk\u0101s vielas. Galven\u0101s terapeitisk\u0101s grupas ietver neirolo\u0123iju, kardiolo\u0123iju, antibakteri\u0101lo terapiju, onkolo\u0123iju, urolo\u0123iju, k\u0101 ar\u012b z\u0101les pret aler\u0123iju un diab\u0113ta \u0101rst\u0113\u0161anai. AS \u201cOlpha\u201d produkti tiek eksport\u0113ti uz vair\u0101k nek\u0101 60 valst\u012bm. Uz\u0146\u0113mum\u0101 str\u0101d\u0101 vair\u0101k nek\u0101 700 darbinieki. AS \u201cOlpha\u201d ir meitasuz\u0146\u0113mumi Francij\u0101, It\u0101lij\u0101, Sp\u0101nij\u0101, V\u0101cij\u0101 un Polij\u0101.<\/p>\n
Skat\u012bties p\u0101r\u0113jos att\u0113lus<\/p>\n","protected":false},"excerpt":{"rendered":"Lai nodro\u0161in\u0101tu uz\u0146\u0113muma att\u012bst\u012bbas pl\u0101nos paredz\u0113to medikamentu ra\u017eo\u0161anu, Baltij\u0101 viens no vado\u0161ajiem z\u0101\u013cu ra\u017eot\u0101jiem AS \u201cOlpha\u201d ieg\u0101d\u0101jies un…\n","protected":false},"author":2,"featured_media":62660,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[23,57,869,77,870,28,29,867,32,33,22,30,31,35,39,38,36,37,34,871,868,40,20,26,27,24,25,54,55,56,21,58],"class_list":{"0":"post-62659","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-zinas-no-arvalstim","8":"tag-aktualitates","9":"tag-arvalstim","10":"tag-biznesa-zinas","11":"tag-bizness","12":"tag-bizness-latvija","13":"tag-breaking-news","14":"tag-breakingnews","15":"tag-dienas-zinas","16":"tag-featured-news","17":"tag-featurednews","18":"tag-headlines","19":"tag-latest-news","20":"tag-latestnews","21":"tag-latvia","22":"tag-latvian","23":"tag-latviesu","24":"tag-latviesu-valoda","25":"tag-latviesuvaloda","26":"tag-latvija","27":"tag-latvijas-biznesa-zinas","28":"tag-latvijas-zinas","29":"tag-lv","30":"tag-news","31":"tag-popularakas-zinas","32":"tag-popularakaszinas","33":"tag-top-stories","34":"tag-topstories","35":"tag-world","36":"tag-world-news","37":"tag-worldnews","38":"tag-zinas","39":"tag-zinas-no-arvalstim"},"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/62659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=62659"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/62659\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/62660"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=62659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=62659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=62659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}